Integer (NYSE:ITGR - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 5.840-6.200 for the period, compared to the consensus estimate of 6.070. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.
Analyst Ratings Changes
A number of analysts recently issued reports on the company. Citigroup lifted their price objective on Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday, December 11th. Piper Sandler reaffirmed an "overweight" rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research report on Friday. Benchmark boosted their price target on Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Friday. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and issued a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $147.67.
Check Out Our Latest Report on Integer
Integer Stock Performance
ITGR traded down $5.26 on Friday, hitting $129.96. 499,343 shares of the stock traded hands, compared to its average volume of 252,248. Integer has a 52 week low of $98.63 and a 52 week high of $146.36. The firm has a market capitalization of $4.36 billion, a PE ratio of 40.11, a P/E/G ratio of 1.82 and a beta of 1.13. The business has a fifty day moving average price of $137.92 and a two-hundred day moving average price of $132.31. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67.
Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The company had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. On average, research analysts predict that Integer will post 5.33 EPS for the current fiscal year.
About Integer
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
